Velky Virginia Villavicencio Vallejo

Velky Virginia Villavicencio Vallejo

Auto-generated profile, based on publicly available information

Velky Virginia Villavicencio Vallejo

Pontificia Universidad Católica del Ecuador

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2026 in Salud Medicina e Innovación Journal
Verified
Journal Article
Open access
PDF file
VVVelky Virginia Villavicencio Vallejo
Velky Virginia Villavicencio Vallejo
KAKarol Natalie Galarza Avila
Karol Natalie Galarza Avila
JCJorge Luis Rivadeneira Chamorro
Jorge Luis Rivadeneira Chamorro
MMMartha Giovanna Herrera Moreno
Martha Giovanna Herrera Moreno
YLYajaira Lizbeth Vargas Ledesma
Yajaira Lizbeth Vargas Ledesma
Introduction: Kounis syndrome (KS) is a medical emergency characterized by the development of acute coronary syndrome secondary to an allergic or anaphylactic reaction, triggered by mast cell degranulation and the release of inflammatory mediators that can induce coronary vasospasm, thrombosis, or plaque rupture (Kounis & Zavras, 1991; Kounis, 2016). Loxoscelism, caused by the bite of spiders of the genus Loxosceles, represents a rare but potentially lethal trigger of KS, which can manifest with multisystem involvement including coronary thrombosis, multiorgan failure, and gastrointestinal complications such as intestinal perforation (Kounis, 2016; Langner et al., 2021). Objective: To synthesize the available evidence on Kounis syndrome type III triggered by loxoscelism, with emphasis on complications of coronary thrombosis, multiorgan failure, and intestinal perforation. Methodology: Systematic review following PRISMA 2020 guidelines (Page et al., 2021). A systematic search was conducted in PubMed, LILACS, SciELO and Cochrane for studies published between 2000 and 2026 reporting KS associated with loxoscelism. Case reports, case series, and observational studies were included. Quality was assessed using the adapted Newcastle-Ottawa scale (Wells et al., 2000). Results: Eight studies reporting KS associated with loxoscelism were identified. Reported cases included acute cardiovascular manifestations with elevation of cardiac biomarkers and electrocardiographic changes compatible with acute coronary syndrome (Navarro-Martinez et al., 2022; Kounis, 2016). Pathophysiology involves mast cell degranulation with release of histamine, leukotrienes, platelet-activating factor, and neutral proteases, which can induce coronary vasospasm and thrombosis (Kounis, 2016). Type III KS, characterized by stent thrombosis, has been documented in patients with pre-existing coronary disease exposed to Loxosceles venom (Mohta et al., 2023). Multiorgan failure has been reported in cases of visceral loxoscelism, with renal, hepatic, hematologic, and cardiovascular involvement (Langner et al., 2021). Conclusion: Kounis syndrome type III secondary to loxoscelism represents an exceptional but potentially lethal complication that requires a high index of suspicion and urgent multidisciplinary management. Early identification of anaphylaxis signs and cardiovascular monitoring are essential to reduce associated morbidity and mortality.

1 July 2026 in ASCE MAGAZINE
Verified
Journal Article
Open access
PDF file
DRDayana Amada Cedeño Romero
Dayana Amada Cedeño Romero
LZLuis Josué Ponce Zavala
Luis Josué Ponce Zavala
KSKarol Dayana Rengifo Santistevan
Karol Dayana Rengifo Santistevan
CRCamila Elizabeth Salinas Ramírez
Camila Elizabeth Salinas Ramírez
VVVelky Virginia Villavicencio Vallejo
Velky Virginia Villavicencio Vallejo
La paraplejia completa (lesión medular ASIA A) conlleva déficit motor irreversible y alta prevalencia de depresión postraumática (DPT). La combinación de interfaces cerebro‑computador (ICC) de circuito cerrado y andamios de nanofibras vasculogénicas podría potenciar la recuperación. Evaluar, mediante una revisión sistemática de la literatura y un modelo computacional in silico, la viabilidad y los efectos clínicos potenciales de un enfoque multimodal (ICC no invasiva + andamio de nanofibras funcionalizado con VEGF) para restaurar función motora y reducir DPT. Métodos: Se realizó una revisión sistemática siguiendo PRISMA 2020 (búsqueda en PubMed, EMBASE, Cochrane, Web of Science hasta diciembre de 2025). Además, se desarrolló una simulación computacional de un andamio de poli(ε‑caprolactona) con péptido mimético de VEGF (QK) y un clasificador EEG para ICC, utilizando parámetros obtenidos de la literatura publicada hasta 2025. Resultados: La revisión incluyó 12 estudios clínicos (N total = 214 pacientes) que reportaron mejoras significativas en la función motora con el uso de ICC no invasivas, con tamaños del efecto moderados (rango de DME: 0,45‑0,78). La simulación predictiva indicó que la combinación con el andamio podría aumentar la precisión de la clasificación EEG en un 15‑20% adicional (p<0,01) y reducir los biomarcadores inflamatorios (IL‑6) en un 40‑50% según modelos de difusión y cinética de liberación. La evidencia sistematizada y los modelos computacionales respaldan el potencial beneficio del enfoque multimodal, aunque se requieren estudios preclínicos y ensayos clínicos para confirmar estos hallazgos. Este trabajo proporciona una base teórica para futuras investigaciones.